Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer therapies for tumours that rely on the alternative lengthening of telomeres ...

Our Vienna Travel Guide! So many layers to this wonderful Austrian city and we barely had time to scratch the surface. Vienna ...